Atalay Demiray, MD, MSc
Cards
About
Biography
Atalay Demiray, MD, MSc, is a second-year PhD student in Health Policy and Management at Yale University. As a first-generation college graduate from Turkiye, he is a prominent advocate of diversity and global health equity.
Atalay earned his Master of Science degree in Health Economics, Policy, and Law from Erasmus University, an endeavor enriched by the Jean Monnet Scholarship. His master's thesis, titled "Regulation of Artificial Intelligence in Medicine: Upholding Public Health," was recognized as the Thesis of the Year in the Netherlands.
Prior to pursuing his master’s degree, he obtained a Doctor of Medicine and a Bachelor of Arts in International Relations from Koc University. With a solid foundation in both medicine and international policy, Atalay is passionately working towards leveraging technological advancements to foster global health equity and improve public health outcomes. His ongoing research at Yale signifies a step further toward melding innovative solutions with pragmatic health policy frameworks.
Education & Training
- MSc
- Erasmus University, Health Economics, Policy and Law (2023)
- MD
- Koc University, Medicine (2022)
- BA
- Koc University, International Relations (2021)
Research
Publications
2024
Beyond "business as usual": lessons from FIFA for fair benefit-sharing in global health.
Wahl B, Butin G, Gombe S, Demiray A, Schwalbe N. Beyond "business as usual": lessons from FIFA for fair benefit-sharing in global health. Health Aff Sch 2024, 2: qxae068. PMID: 39050554, DOI: 10.1093/haschl/qxae068.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2023
Tirzepatide decreases systolic and diastolic blood pressure.
Copur S, Demiray A, Cherney D, Tuttle K, Kanbay M. Tirzepatide decreases systolic and diastolic blood pressure. Eur J Intern Med 2023, 114: 135-137. PMID: 37045710, DOI: 10.1016/j.ejim.2023.04.005.Peer-Reviewed Original Research
2022
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? Eur J Intern Med 2022, 103: 4-12. PMID: 35508444, DOI: 10.1016/j.ejim.2022.04.022.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2021
Virulence Determinants of Colistin-Resistant K. pneumoniae High-Risk Clones.
Dogan O, Vatansever C, Atac N, Albayrak O, Karahuseyinoglu S, Sahin OE, Kilicoglu BK, Demiray A, Ergonul O, Gönen M, Can F. Virulence Determinants of Colistin-Resistant K. pneumoniae High-Risk Clones. Biology (Basel) 2021, 10 PMID: 34068937, DOI: 10.3390/biology10050436.Peer-Reviewed Original ResearchRole of Klotho in the Development of Essential Hypertension.
Kanbay M, Demiray A, Afsar B, Covic A, Tapoi L, Ureche C, Ortiz A. Role of Klotho in the Development of Essential Hypertension. Hypertension 2021, 77: 740-750. PMID: 33423524, DOI: 10.1161/HYPERTENSIONAHA.120.16635.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements